The LineLens Philosophy
Understanding the Edge
A likely winner is not always a worthwhile bet. The odds you receive matter just as much as the outcome you expect.
LineLens starts with a specific question: How likely is this bet to win, and does the available price justify the risk?
What the model’s percentage means
Our goal is to provide an estimated probability for the exact bet being evaluated:
- Moneyline: the chance a team wins outright.
- Spread or run line: the chance a team covers the stated line.
- Total: the chance the combined score finishes over or under the stated number.
A team can have a strong chance of winning its game and a much lower chance of covering its spread. Those are different questions, and they require different estimates.
A 56% estimated chance of covering means the model expects that bet to win roughly 56 times in 100 comparable situations—if the estimate is accurate. It is not a promise about tonight’s game.
What is expected value?
Expected value, or EV, compares the estimated likelihood of winning with what the bet pays and what you risk losing.
Positive EV means the estimated probability and offered payout suggest a favorable average return over repeated comparable bets. It does not guarantee a profit on any single bet—or over any particular period.
A hypothetical example
Team A −3.5 at −110
| Model-estimated chance of covering | 56% |
| Break-even probability | 52.38% |
| Probability advantage | 3.62 percentage points |
| Estimated EV per $100 risked | +$6.91 |
At −110, a bettor needs to win approximately 52.38% of bets to break even, assuming no pushes. A 56% estimate is 3.62 percentage points above that threshold.
For every $100 risked, the estimated EV is approximately +$6.91. The actual result of this individual bet would be about $90.91 in profit if it wins or a $100 loss if it loses.
That calculation depends on the probability estimate being sound. An inaccurate model can make an apparent edge disappear.
This example is educational and is not a LineLens prediction or performance result.
Why the line and price matter
An assessment applies to the exact bet evaluated. Team A −3.5 is different from Team A −4.5. Odds of −110 are different from −125.
If your sportsbook offers a different line or price, the original assessment may no longer apply. A favorable opportunity can disappear as the market moves.
What is closing line value?
Closing line value, or CLV, compares the line or odds you obtained with those available near the start of the event.
For example, taking the same team on the moneyline at +110 before it closes at −110 means you secured a better payout than the closing market offered.
We intend to track CLV alongside results to help evaluate our decisions. Comparisons must use the same betting market and account for changes in the line and sportsbook margin. Beating the closing price is useful evidence, but it does not guarantee a win or establish profitability by itself.
Probability is different from confidence
Probability describes how often the model estimates a bet will win.
Confidence describes how much trust the available evidence supports in that estimate. Missing information, uncertain lineups, and limited testing can reduce confidence—even when a displayed probability looks attractive.
Our approach is to make uncertainty visible.
Why good decisions still lose
Sports outcomes are uncertain. A bet with a genuine 56% chance of winning still has a 44% chance of losing. Losing streaks can occur even with positive expected value.
That is why our philosophy emphasizes consistent risk limits, careful recordkeeping, and evaluation over many bets. Increasing stakes to recover losses does not improve the underlying edge.
Our standard
LineLens is being developed around transparent estimates, documented methods, and measurable results. We will distinguish model estimates from demonstrated performance and evaluate predictions against outcomes and market benchmarks.
Models remain under validation. No profitable betting edge has yet been established.
No guarantees. No obligation to bet every day. When the evidence is insufficient or the price is wrong, passing is part of the strategy.